CapsoVision CV 深滬

等待開盤 10-09 09:30:00 美东时间

6.69

+0.150

+2.29%

華盛通

立即下載

最高6.70
今開6.48
成交量 4.18万股
最低 6.41
昨收 6.54
總市值 3.56亿
52周最高 15.37
市盈率 ^靜 --
換手率 0.08%
52周最低 4.50
委比 -23.99%
總股本 5321.04万
歷史最高 15.37
量比 0.52
振幅 4.43%
歷史最低 3.4341
每手 1
風險率 1.79%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus System

AI Highlights is designed to support physicians in the review of small bowel capsule endoscopy studies collected from adult and pediatric patients (over two years of age) in whom the study was performed due to suspected small bowel bleeding, specifically to reduce the time taken to review capsule en...

09-28 21:02
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®

CapsoVision's AI Highlights tool, designed to assist physicians in reviewing small bowel capsule endoscopy studies for suspected bleeding, has received FDA clearance. The AI tool helps reduce review time by identifying and highlighting abnormal lesions, integrating with CapsoView and CapsoCloud platforms. CapsoVision CEO Johnny Wang highlighted this as a significant milestone, emphasizing the potential of AI to enhance physician efficiency and pe...

09-28 13:00
CapsoVision Announces Offering Of 3,163,444 Shares Of Common Stock At A Price Of $5.69/Share, Net Proceeds Expected At $17.83M

CapsoVision, Inc. 3,163,444 Shares of Common Stock We are offering 3,163,444 shares of our common stock, par value $0.001 per share, under this prospectus supplement directly to a number of investors (collectively, the "Investors"), including Star One Global Capital Limited and Eliyahou Harari a...

09-19 02:39
CapsoVision to Participate in Upcoming Investor Conferences

CapsoVision, Inc. announced that its executives, Johnny Wang, David Garcia, and Doug Atkinson, will participate in two upcoming investor conferences: the H.C. Wainwright Global Investment Conference (September 14-16 in NYC) and the ROTH Healthcare Opportunities Conference (September 29 in NYC). The company will present an on-demand presentation on September 11 and offer one-on-one investor meetings. CapsoVision, a medical tech company, focuses on...

09-03 20:05
Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

Outlook Therapeutics appoints Kevin Lundquist as Chief Financial Officer, effective September 1, 2026. Lundquist, with over 20 years of experience in finance and operations across pharmaceutical and medical technology industries, will help build financial and operational infrastructure for the U.S. commercial launch of LYTENAVA™ following its FDA approval. He previously served as CFO at CapsoVision, Inc., leading its IPO, and has extensive experi...

08-27 20:05
CapsoVision Enters Sales Agreement With Cantor FitzGerald For ATM Offering Up To $100M

CapsoVision Enters Sales Agreement With Cantor FitzGerald For ATM Offering Up To $100M

08-14 05:10
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026

CapsoVision, Inc. (NASDAQ: CV), a medical technology company, announced it will release its second quarter 2026 financial results on August 13, 2026, after market close. A conference call and live webcast will be held at 1:30 pm PT / 4:30 pm ET on the same day to discuss the results and provide a corporate update. Investors can join the call by dialing (800) 715-9871 or (646) 307-1963 with conference ID 9178774. The webcast will be available on t...

07-30 20:05
ETF Boom Turns To Shakeout As Defiance, YieldMax Close Multiple Funds

Defiance and YieldMax are closing six ETFs as the U.S. ETF market tops 5,000 funds, highlighting growing pressure on smaller products.

06-03 06:21
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Monday.

05-18 20:02

派息除權日	每股總股息	派息日期
2012-05-02	0.23	2012-05-15
2012-02-01	0.23	2012-02-15
2011-11-02	0.23	2011-11-15
2011-08-03	0.23	2011-08-15
2011-04-29	0.23	2011-05-13
2011-02-02	0.23	2011-02-15
2010-11-03	0.23	2010-11-15
2010-07-30	0.23	2010-08-13
2010-04-30	0.23	2010-05-14
2010-02-03	0.23	2010-02-15
2009-10-30	0.23	2009-11-13
2009-07-31	0.23	2009-08-14
2009-05-01	0.23	2009-05-15
2009-01-30	0.23	2009-02-13
2008-10-28	0.23	2008-11-14
2008-07-29	0.23	2008-08-15
2008-04-28	0.23	2008-05-15
2008-01-29	0.23	2008-02-15
2007-10-29	0.23	2007-11-15
2007-07-27	0.23	2007-08-15
2007-04-26	0.23	2007-05-15
2007-01-29	0.23	2007-02-15
2006-10-27	0.23	2006-11-15
2006-07-27	0.23	2006-08-15
2006-04-26	0.23	2006-05-15
2006-01-27	0.23	2006-02-15
2005-10-27	0.23	2005-11-15
2005-07-27	0.23	2005-08-15
2005-04-26	0.23	2005-05-13
2005-01-27	0.23	2005-02-15
2004-10-28	0.23	2004-11-15
2004-07-26	0.23	2004-08-13
2004-04-26	0.23	2004-05-14
2004-01-26	0.23	2004-02-13
2003-10-27	0.22	2003-11-14
2003-07-28	0.22	2003-08-15
2003-04-28	0.22	2003-05-15
2003-01-27	0.22	2003-02-14
2002-10-29	0.22	2002-11-15
2002-07-29	0.22	2002-08-15
2002-04-26	0.22	2002-05-15
2002-01-29	0.22	2002-02-15
2001-10-29	0.22	2001-11-15
2001-07-27	0.22	2001-08-15
2001-04-26	0.22	2001-05-15
2001-01-29	0.22	2001-02-15
2000-10-27	0.22	2000-11-15
2000-07-27	0.22	2000-08-15
2000-04-26	0.22	2000-05-15
2000-01-27	0.22	2000-02-15
1999-10-27	0.22	1999-11-15
1999-07-28	0.22	1999-08-13
1999-04-28	0.22	1999-05-14
1999-01-27	0.22	1999-02-15
1998-10-28	0.22	1998-11-13
1998-07-29	0.22	1998-08-14
1998-04-28	0.22	1998-05-15
1998-01-28	0.22	1998-02-13
1997-10-29	0.22	1997-11-14
1997-07-29	0.22	1997-08-15
1997-04-28	0.22	1997-05-15
1997-01-29	0.22	1997-02-14
1996-10-29	0.22	1996-11-15
1996-07-29	0.22	1996-08-15
1996-04-26	0.20	1996-05-15
1996-01-29	0.20	1996-02-15
1995-10-27	0.20	1995-11-15
1995-07-27	0.20	1995-08-15
1995-04-24	0.20	1995-05-15
1995-01-25	0.20	1995-02-15
1994-10-25	0.35	1994-11-15
1994-07-25	0.35	1994-08-15
1994-04-22	0.35	1994-05-13
1994-01-25	0.35	1994-02-15
1993-10-25	0.35	1993-11-15
1993-07-23	0.35	1993-08-13
1993-04-23	0.35	1993-05-14
1993-01-08	0.53	1993-02-12
1992-10-23	0.52	1992-11-13
1992-07-24	0.52	1992-08-14
1992-04-24	0.52	1992-05-15
1992-01-24	0.52	1992-02-14
1991-10-25	0.52	1991-11-15
1991-07-24	0.52	1991-08-14
1991-04-23	0.52	1991-05-14
1991-01-25	0.52	1991-02-15
1990-10-25	0.52	1990-11-15
1990-07-24	0.52	1990-08-14
1990-04-23	0.51	1990-05-14
1990-01-25	0.51	1990-02-15
1989-10-25	0.51	1989-11-15
1989-07-24	0.51	1989-08-14
1989-04-23	0.50	1989-05-14
1989-01-25	0.50	1989-02-15
1988-10-25	0.50	1988-11-15
1988-07-24	0.50	1988-08-14
1988-04-24	0.47	1988-05-12
1988-01-25	0.47	1988-02-15
1987-10-26	0.47	1987-11-13
1987-07-26	0.47	1987-08-13
1987-04-23	0.47	1987-05-14
1987-01-26	0.47	1987-02-13
1986-10-27	0.48	1986-11-14
1986-07-24	0.48	1986-08-14
1986-04-24	0.48	1986-05-14
1986-01-27	0.48	1986-02-15
1985-10-25	0.47	1985-11-15
1985-07-25	0.47	1985-08-15
1985-04-24	0.47	1985-05-15
1985-01-25	0.47	1985-02-15
1984-10-25	0.47	1984-11-15
1984-07-25	0.45	1984-08-15
1984-04-24	0.45	1984-05-15
1984-01-25	0.45	1984-02-15
1983-09-19	0.60	1983-11-15
1983-07-25	0.56	1983-08-15
1983-04-25	0.56	1983-05-13
1983-01-25	0.56	1983-02-15
1982-10-25	0.56	1982-11-15
1982-07-26	0.53	1982-08-13
1982-04-13	0.53	1982-05-14
1982-01-25	0.53	1982-02-15
1981-10-26	0.53	1981-11-13
1981-07-27	0.48	1981-08-14
1981-04-24	0.48	1981-05-15
1981-01-26	0.48	1981-02-13
1980-10-27	0.48	1980-11-14
1980-07-25	0.46	1980-08-15
1980-04-24	0.46	1980-05-15
1980-01-25	0.46	1980-02-15
1979-10-25	0.46	1979-11-15
1979-07-25	0.41	1979-08-15
1979-04-24	0.41	1979-05-15
1979-01-25	0.41	1979-02-15
1978-10-25	0.36	1978-11-15
1978-07-24	0.36	1978-08-15
1978-04-24	0.36	1978-05-15
1978-01-25	0.36	1978-02-15
1977-10-25	0.34	1977-11-15
1977-07-25	0.34	1977-08-15
1977-04-25	0.34	1977-05-13
1977-01-25	0.34	1977-02-15

公司名稱	CapsoVision, Inc.
行業分類	Medical Specialties
業務描述	CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn's disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.

CapsoVision CV 深 滬

6.69

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

CapsoVision CV 深滬